Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Look for it on the next Proxy.

On November 10, 2015, the closing bid price of our common stock dropped below $0.01. On December 14, 2015, we received a letter from the OTC Markets Group notifying us that we were not in compliance with the minimum bid price requirement set forth in the Standards for Continued Eligibility for OTCQB pursuant to the OTCQB Standards Section 2.3(2). Pursuant to such section, we have a 180 calendar day grace period to regain compliance. In order to regain compliance, the minimum closing bid price of our common stock must be $0.01 or greater for ten consecutive trading days. If we do not regain compliance by the end of such 180-day period, or by June 11, 2016, our common stock will be removed from the OTCQB marketplace.

"We are evaluating various alternative courses of action to regain compliance with the OTCQB minimum bid price requirement, including submitting a proposal at our next annual meeting for our shareholders to approve a reverse stock split."

IN a few days, I'll probably post the only numbers that I think are of concern to them, and the sobering statistics that probably keep the BOD up at night; and they have nothing to do with the MMP.
6
Jan 19, 2016 01:15PM
1
Jan 19, 2016 02:11PM
5
Jan 20, 2016 01:21PM
1
Jan 21, 2016 06:01PM
Share
New Message
Please login to post a reply